EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Pain alleviation in diabetic neuropathy using hybrid closed loop insulin pumps (PAINLESS) – A randomised crossover trial protocol

Simon Alexander Berry iD, Ahmed Iqbal, Jackie Elliott, Rajiv Gandhi, Abdul Paracha iD, Vaios Koutroukas iD, Mohummad Shaan Goonoo iD, Mahnoor Fatima Haq, Andrew Gerges iD, Gordon Sloan, Solomon Tesfaye, Pratik Choudhary und 1 weitere

PLOS One · 2026

DOI: 10.1371/journal.pone.0357573 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, 2026. Verfasst von Simon Alexander Berry und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Insulin Infusion Systems, Diabetes Mellitus, Type 1, Insulin. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tandem Diabetes Care.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction Painful diabetic neuropathy (PDN) is a common complication of diabetes that leads to significant co-morbidity. Emerging evidence suggests glycaemic variability may be linked to fluctuations in pain intensity. Hybrid closed loop (HCL) systems reduce glycaemic variability, raising the possibility that they may modify pain intensity. This study aims to evaluate the effects of HCL use on pain intensity in people with PDN. Materials and methods PAINLESS is a two-centre, randomised cross-over study, recruiting 49 adults with type 1 diabetes and PDN. Each participant will complete two 12-week intervention periods in a randomised sequence (1:1): one with standard care including continuous glucose monitoring (CGM) and one with HCL using the Tandem t:slim X2 insulin pump with Control-IQ technology. The primary outcome is the change in 7-day average 24-hour pain intensity [rated on a numerical scale from 0-10 (NRS)] from baseline to the end of each 12-week intervention period as measured by daily pain diaries. Secondary outcomes include measures of pain trajectory/durability [responder rates (30% and 50% pain reduction in 7-day NRS), and the AUC for daily NRS scores], functional and quality of life outcomes [Short Form Health Survey (SF-36), and Short Form of the Brief Pain Inventory (BPI-MSF)], mood [Beck Depression Inventory (BDI)], health status [EQ-5D-5L], and global improvement [participant and clinician reported global impression of change]. Exploratory endpoints will harness neurophysiological assessments including Sudoscan, DPN-Check, Vagus and Vibrosense, and sleep and activity data from Withings devices. Statistical analyses will employ an intention-to-treat approach and mixed effect models. Timelines 24-month trial: 18 months recruitment/follow up, 6 months close-out, analyses and dissemination. Registration Details ISRCTN24233750 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NeuropathiesInsulin Infusion SystemsDiabetes Mellitus, Type 1InsulinPain ManagementPainHumansCross-Over StudiesContinuous Glucose MonitoringQuality of LifeRandomized Controlled Trials as TopicAdultFemaleMalePain MeasurementMiddle Aged

Substanzen

Insulin

Autor:innen und Institutionen

  • School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom.
  • Department of Diabetes and Endocrinology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
  • Diabetes Research Centre, University of Leicester, Leicester, United Kingdom.

ORCID-Profile: Simon Alexander Berry, Abdul Paracha, Vaios Koutroukas, Mohummad Shaan Goonoo, Andrew Gerges

Förderung

  • Tandem Diabetes Care

Zitieren

APA

Berry, S. A., Iqbal, A., Elliott, J., Gandhi, R., Paracha, A., Koutroukas, V., Goonoo, M. S., Haq, M. F., Gerges, A., Sloan, G., Tesfaye, S., Choudhary, P., & Selvarajah, D. (2026). Pain alleviation in diabetic neuropathy using hybrid closed loop insulin pumps (PAINLESS) – A randomised crossover trial protocol. PLOS One. https://doi.org/10.1371/journal.pone.0357573

Vancouver

Berry SA, Iqbal A, Elliott J, Gandhi R, Paracha A, Koutroukas V, et al. Pain alleviation in diabetic neuropathy using hybrid closed loop insulin pumps (PAINLESS) – A randomised crossover trial protocol. PLOS One. 2026. doi:10.1371/journal.pone.0357573

BibTeX
@article{Berry2026,
  author = {Berry, Simon Alexander and Iqbal, Ahmed and Elliott, Jackie and Gandhi, Rajiv and Paracha, Abdul and Koutroukas, Vaios and Goonoo, Mohummad Shaan and Haq, Mahnoor Fatima and Gerges, Andrew and Sloan, Gordon and Tesfaye, Solomon and Choudhary, Pratik and Selvarajah, Dinesh},
  title = {Pain alleviation in diabetic neuropathy using hybrid closed loop insulin pumps (PAINLESS) – A randomised crossover trial protocol},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0357573}
}
Kostenlos starten →